- Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
-
Dutta D, Agarwal A, Maisnam I, Singla R, Khandelwal D, Sharma M
- KMID: 2515464
- Endocrinol Metab.
- 2021 Apr;36(2):374-387.
- doi: 10.3803/EnM.2020.818
Background: No meta-analysis has holistically analysed and summarised the efficacy and safety of gemigliptin in type 2 diabetes. The meta-analysis addresses this knowledge gap. Methods: Electronic databases were searched for randomised... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic approach to rickets: an Endocrine Society of Bengal (ESB) consensus statement
-
Roy A, Chowdhury AS, Ray A, Baidya A, Roychowdhury B, Sarkar D, Sanyal D, Maisnam I, Biswas K, Pandit K, Banerjee M, Raychaudhuri M, Sengupta N, Chakraborty PP, Mukhopadhyay P, Raychaudhuri P, Sahana PK, Palui R, Bhattacharjee R, Mukhopadhyay S, Mukhopadhyay S, Ray S, Goswami S, Chowdhury S, Pramanik S, Swar SC, Ghosh S, Mondal S, Das TC
- KMID: 2560464
- Ann Pediatr Endocrinol Metab.
- 2024 Oct;29(5):284-307.
- doi: 10.6065/apem.2448044.022
Rickets, one of the leading causes of bony deformities and short stature, can be calciopenic (inciting event is defective intestinal calcium absorption) or phosphopenic (inciting event is phosphaturia). Early diagnosis... -
- CITED
-
- Close
- SHARE
-
- Close
